22
Princess Margaret Cancer Centre
Who can join a clinical trial?
To participate in a clinical trial, the patient must have a referral from their
doctor. Each clinical trial has eligibility guidelines based on the questions
the research is trying to answer.
Common criteria:
• Having a certain type or stage of cancer
• Having received a certain kind of therapy in the past
• Having adequate organ functions such as kidney,
liver and bone marrow functions
These criteria ensure that people in the trial are as alike as possible. This
way doctors can be sure that the results are due to the treatment being
studied and not other factors.
Safety:
Some people have health problems other than cancer that could be made
worse by the treatments in a study. Patients interested in joining a trial will
receive medical tests to be sure they are not put at increased risk.
Accurate and meaningful study results:
Patients may not be able to join some clinical trials if they have already
had another kind of cancer treatment. Otherwise, doctors could not be
sure whether their results were due to the treatment being studied or
the earlier treatment.
Clinical trials
at Princess Margaret CANCER CENTRE
The Tumor Immunotherapy Program has a number of studies that are
currently recruiting patients. For information about how to be referred
to one of these studies, please contact the team at
TIP@uhn.ca.
610 University Avenue,
Toronto, ON
M5G 2M9
Phone: 416-946-6560
Toll Free:
1-866-224-6560
Fax: 416-946-6563
info@thepmcf.caCharitable Organization
No. 88900 7597 RR0001
Editor-In-Chief
Christine Lasky
Managing Editor
Ivy Cuervo
Art Director
Fabio Eymael
Production Editor
Geoff Nixon
Contributors
Kenzie Broddy
Daniel Cavarra
Lexie Hinde
Arianna Ongaro
Scientific Advisors
Dr. Derek Clouthier
Dr. Linh Nguyen
Dr. Pamela Ohashi
Dr. Christopher Paige
Dr. Lillian Siu
Photography
Fabio Eymael
Dr. Rita Serda
Copy Editor
Barb Crisp